In 1991, Congress enacted legislation that required each state to use a minimum amount of crumb-rubber modified (CRM) hot-mix asphalt in road paving operations. However, because of concerns over the lack of information on the environmental and human health effects caused by CRM asphalts, Congress passed a temporary moratorium and directed that these effects be evaluated. In 1995, Congress eliminated the requirement to use CRM asphalts but continued the requirement to conduct research. Because asphalt emissions may contain mutagenic compounds (e.g., polycyclic aromatic hydrocarbons), their mutagenic potential was investigated using a spiral Salmonella mutagenicity assay. Asphalt emissions were collected above open ports of heated asphalt storage tanks, at seven hot-mix plants in six states. At each site, asphalt emissions from the same asphalt formulation, with or without crumb-rubber, were collected on 37-mm polytetrafluoroethylene filters at 28.3 L/min over approximately 8 to 10 hrs. Asphalt samples were extracted with methylene chloride, evaporated to dryness for total mass determination, and dosing solutions were prepared in dimethyl sulfoxide. The spiral Salmonella mutagenicity assay was conducted using tester strains TA98 and TA100, with and without 10% S9 metabolic activation. Because of dispersion problems (sample formed beads on the plate) with samples from the first three sites, the remaining samples were extracted using hexane and half of the extract was fractionated into aliphatic compounds, polycyclic aromatic compounds, and polar compounds using NIOSH Method 5800. These fractions and the remaining extract were dried for total mass determination. As before, dosing solutions were prepared, and the spiral Salmonella assay was conducted. Test doses ranged from 13 to 900 u/mL equivalents per plate. None of the asphalt emissions or fractions were found to be mutagenic at the doses tested.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.